Evaluation of the efficacy and tolerability of two different formulations of lercanidipine versus placebo after once-daily administration in mild to moderate hypertensive patients
- 31 August 1993
- journal article
- Published by Elsevier in Current Therapeutic Research
- Vol. 54 (2) , 248-253
- https://doi.org/10.1016/s0011-393x(05)80608-3
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Evaluation of the once-daily activity of REC 15/2375 in the treatment of mild to moderate hypertensionCurrent Therapeutic Research, 1992
- Calcium Entry Blockers in the Treatment of HypertensionPublished by American Medical Association (AMA) ,1989
- 1989 Guidelines for the management of mild hypertension: memorandum from a WHO/ISH MeetingJournal Of Hypertension, 1989
- New insights and new approaches for the treatment of essential hypertension: Selection of therapy based on coronary heart disease risk factor analysis, hemodynamic profiles, quality of life, and subsets of hypertensionAmerican Heart Journal, 1989
- Effects of a new calcium antagonist, REC 15/2375, on cardiac contractility of conscious rabbitsPharmacological Research, 1989
- The 1988 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood PressureArchives of internal medicine (1960), 1988
- Calcium channel antagonists, part I: Fundamental properties: Mechanisms. classification, sites of actionCardiovascular Drugs and Therapy, 1987
- Role of calcium antagonists in systemic hypertensionThe American Journal of Cardiology, 1987
- Age, race, blood pressure and renin: Predictors for antihypertensive treatment with calcium antagonistsThe American Journal of Cardiology, 1985
- Five-Year Findings of the Hypertension Detection and Follow-up ProgramPublished by American Medical Association (AMA) ,1979